Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 12/8/2020
SIETES contiene 93083 citas

 1 a 20 de 36 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Robblee JV, Butterfield RJ, Kang AM, Smith JM. Triptan and ergotamine overdoses in the United States. Analysis of the National Poison Data System. Neurology 2020:1. [Ref.ID 103505]
2. Cita con resumen
Comte H, Auffret M, Lelièvre B, Béné J, Steen P, Gautier S. Tachycardie et douleurs précordiales sous agomélatine: à propos d'un cas. Therapie 2013;68:324-5. [Ref.ID 96645]
Rangel C, Shu RG, Lazar LD, Vittinghoff E, Hsue PY, Marcus GM. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med 2010;170:874-9. [Ref.ID 88581]
4.Enlace a cita original
Cooper A, Timmis A, Skinner J, on behalf of the Guideline Development Group. Assessment of recent onset chest pain or discomfort of suspected cardiac origin: summary of NICE guidance. BMJ 2010;340:3 de abril. [Ref.ID 88217]
6. Cita con resumen
Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007;41:1411-26. [Ref.ID 80953]
7.Tiene citas relacionadas Cita con resumen
Malozowski S. Exenatide in combination therapy: small study, big market, and many unanswered questions. Ann Intern Med 2007;146:527-8. [Ref.ID 79742]
8.Tiene citas relacionadas Cita con resumen
Zinman B, Hoogwerf BJ, Durán García SD, Milton DR, Giaconia JM, Kim DD, Trautmann ME, Brodows RG. The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes. A randomized trial. Ann Intern Med 2007;146:477-85. [Ref.ID 79740]
Wang W, Huang JQ, Zheng GF, Wong WM, Lam S-K, Karlberg J, Xia HHX, Fass R, Wong BCY. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?. Arch Intern Med 2005;165:1222-8. [Ref.ID 74478]
Curzen N. Troponin in patients with chest pain. BMJ 2004;329:1357-8. [Ref.ID 72139]
11.Tiene citas relacionadas
Gibbons RJ. Nitroglycerin: should we still ask?. Ann Intern Med 2003;139:1036-7. [Ref.ID 68705]
12.Tiene citas relacionadas Cita con resumen
Henrikson CA, Howell EE, Busch DE, Miles S, Meininger GR, Friedlander T, Bushnell AC, Chandra-Strobos N. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med 2003;139:979-86. [Ref.ID 68701]
Blowey DL. Safety of the newer antihypertensive agents in children. Expert Opin Drug Saf 2002;1:39-43. [Ref.ID 62150]
14. Cita con resumen
Iglesias-Rogers G. Poor prognosis for Argentina's health system. Lancet 2001;358:2059. [Ref.ID 60075]
15. Cita con resumen
Ferrari MD, Roon K I, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001;358:1668-75. [Ref.ID 59943]
Martin RM, Dunn NR, Freemantle S, Shakir S. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. Br J Clin Pharmacol 2000;50:366-72. [Ref.ID 53002]
17.Tiene citas relacionadas
Muir DF, McCann G, Hillis WS. Triptans and coronary spasm. Reply. Clin Pharmacol Ther 2000;68:338. [Ref.ID 52610]
18.Tiene citas relacionadas
Welch KM, Saiers J, Salonen R. Triptans and coronary spasm. Clin Pharmacol Ther 2000;68:337-8. [Ref.ID 52609]
19. Cita con resumen
Canto JG, Shlipak MG, Rogers W J, Malmgren JA, Frederick PD, Lambrew CT, Ornato JP, Barron HV, Kiefe C I. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000;283:3223-9. [Ref.ID 51616]
Seleccionar todas
 1 a 20 de 36 siguiente >>